Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120,284,725
-
Total 13F shares
-
2,138,394
-
Share change
-
+639,202
-
Total reported value
-
$20,743,048
-
Price per share
-
$9.70
-
Number of holders
-
13
-
Value change
-
+$6,193,886
-
Number of buys
-
6
-
Number of sells
-
9
Institutional Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q4 2019
As of 31 Dec 2019,
IMMUNIC, INC. - Common Stock (IMUX) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,138,394 shares.
The largest 10 holders included
Omega Fund Management, LLC, Artal Group S.A., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Verition Fund Management LLC, WELLS FARGO & COMPANY/MN, Tower Research Capital LLC (TRC), and INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.